Home > Journals > Minerva Endocrinologica > Past Issues > Articles online first > Minerva Endocrinologica 2020 Jun 16

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

 

Minerva Endocrinologica 2020 Jun 16

DOI: 10.23736/S0391-1977.20.03216-2

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

COVID-19: The Endocrine opportunity in a pandemic

Subhankar CHATTERJEE 1 , Ritwik GHOSH 2, Payel BISWAS 3, Souvik DUBEY 4, Rishi T. GURIA 1, Chandra B. SHARMA 1, Sanjay KALRA 5

1 Department of General Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India; 2 Department of General Medicine, Burdwan Medical College and Hospital, Burdwan, West Bengal, India; 3 Department of Radiodiagnosis, Care & Cure Hospital, Barasat, West Bengal, India; 4 Department of Neuromedicine, Bangur Institute of Neurosciences, Institute of Post Graduate Medical Education and Research & SSKM Hospital, Kolkata, West Bengal, India; 5 Department of Endocrinology, Bharti Hospital, Karnal, Haryana, India


PDF


The 2019 Coronavirus disease (COVID-19) pandemic has disrupted the social, economical and medical system worldwide. Although it is strictly an infectious disease, its intricate bidirectional relationship with various non-communicable metabolic diseases and endocrinological factors has been observed. While diabetes, hypertension, obesity have been found to be independent risk factors for COVID-19 disease severity and mortality, more inclination towards sedentary lifestyle, psychosocial stress at this critical time may be the harbingers of metabolic syndrome. Thus, endocrinologists have a great opportunity to play their role to combat this pandemic. This paper examines how various endocrinological disorders influence the dynamics of COVID-19 and vice versa. Moreover, it also intends to review the clinical guidelines to be adopted in practice of endocrinology in this trying time.


KEY WORDS: COVID-19; SARS-CoV-2; Coronavirus; Endocrinology; Endocrine; Hormone; Corticosteroid; Diabetes; Thyroid; Thymus; Obesity; Metabolic; Parathyroid; Vitamin D; ACE2; Mortality; Ageing; Gender difference; Androgen; Telemedicine; Drug repurposing

top of page